In a recent article for the Brutkasten magazine RIANA Therapeutics CEO Anna Orlova, Christopher Trummer (Celeris Therapeutics), and Peter Llewellyn-Davies (President Biotech-Austria) discuss the challenges and opportunities facing the biotech industry.
“It is always difficult to explain to people who are not familiar with the life science industry what our challenges are and why we are not yet making sales.” says Anna Orlova.
“Fact is, Biotech is not easy. But it is also a fact that we do something for the health of humanity and that we do it with passion. And the fact is that biotech is one of the most innovative industries in Austria and makes a significant contribution to achieving one of the highest research and development rates in the EU. Austria took third place in the EU, and the trend is rising.”, says Peter Llewellyn-Davies.
Link: Der Brutkasten Magazin
RIANA Therapeutics 